In vivo proton T1 relaxation times of mouse myocardial metabolites at 9.4 T

Magnetic Resonance in Medicine

Volumn 73, Issue 6, 2015, Pages 2069-2074

  Bakermans, Adrianus J ^a,b   Abdurrachim, Desiree ^a   Geraedts, Tom R ^a   Houten, Sander M ^b,c   Nicolay, Klaas ^a   Prompers, Jeanine J ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

1H MRS; metabolite T1 relaxation; mouse heart; myocardial metabolism; PRESS; saturation recovery

Indexed keywords

AMINO ACIDS; BIOMOLECULES; MAGNETIC RESONANCE; MAMMALS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESSES (MACHINE TOOLS); RELAXATION TIME;

MOUSE HEART; MYOCARDIAL METABOLISMS; PARTIAL SATURATION; SIGNAL STABILITY; STANDARD DEVIATION; T1 RELAXATION; T1 RELAXATION TIME; ^1H-MRS;

METABOLITES;

CARBENE; CARNITINE; CHOLINE; CREATINE; CREATINE METHYL; PROTON; TAURINE; TRIACYLGLYCEROL; TRIMETHYLAMINE; UNCLASSIFIED DRUG; WATER;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; ARTIFACT; CARDIAC GATED IMAGING; CONTROLLED STUDY; HEART MUSCLE; HEART MUSCLE METABOLISM; IN VIVO STUDY; MAGNET; MALE; METABOLITE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RADIOFREQUENCY; RELAXATION TIME; RESPIRATORY GATED IMAGING; SIGNAL NOISE RATIO; STEADY STATE; ANIMAL; C57BL MOUSE; ELECTROCARDIOGRAPHY; METABOLISM; PROCEDURES;

ANIMALS; CARDIAC-GATED IMAGING TECHNIQUES; ELECTROCARDIOGRAPHY; MICE; MICE, INBRED C57BL; MYOCARDIUM; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RESPIRATORY-GATED IMAGING TECHNIQUES;

EID: 84929643546     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25340     Document Type: Article

References (32)

1. Fillmore N, Mori J, Lopaschuk GD,. Mitochondrial fatty acid oxidation alterations in heart failure, ischemic heart disease, and diabetic cardiomyopathy. Br J Pharmacol 2014; 171: 2080-2090.
2. Molkentin JD, Robbins J,. With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol 2009; 46: 130-136.
3. 1H magnetic resonance spectroscopic imaging. Magn Reson Med 1994; 32: 175-180.
4. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG,. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003; 49: 417-423.
5. 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 2007; 245: 251-257.
6. 1H MRS at 3 Tesla. Magn Reson Med 2011; 66: 619-624.
7. Bottomley PA, Weiss RG,. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998; 351: 714-718.
8. Nakae I, Mitsunami K, Omura T, et al., Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 2003; 42: 1587-1593.
9. Weiss K, Martini N, Boesiger P, Kozerke S,. Metabolic MR imaging of regional triglyceride and creatine content in the human heart. Magn Reson Med 2012; 68: 1696-1704.
10. Epstein FH,. MR in mouse models of cardiac disease. NMR Biomed 2007; 20: 238-255.
11. 1H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism. Heart Fail Rev 2012; 18: 657-668.
12. Kober F, Troalen T, Bernard M,. Recent developments in small animal cardiovascular MRI. Curr Cardiovasc Imaging Rep 2014; 7: 9249.
13. Whalen M, Shapiro JI,. Controlled ventilation during NMR spectroscopic studies: hemodynamic and biochemical consequences. Magn Reson Imaging 1991; 9: 229-234.
14. Cassidy PJ, Schneider JE, Grieve SM, Lygate CA, Neubauer S, Clarke K,. Assessment of motion gating strategies for mouse magnetic resonance at high magnetic fields. J Magn Reson Imaging 2004; 19: 229-237.
15. 1H-MRS in the mouse. Magn Reson Med 2004; 52: 1029-1035.
16. Hankiewicz JH, Banke NH, Farjah M, Lewandowski ED,. Early impairment of transmural principal strains in the left ventricular wall after short-term, high-fat feeding of mice predisposed to cardiac steatosis. Circ Cardiovasc Imaging 2010; 3: 710-717.
17. Bakermans AJ, Geraedts TR, van Weeghel M, Denis S, João Ferraz M, Aerts JM, Aten J, Nicolay K, Houten SM, Prompers JJ,. Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular function. Circ Cardiovasc Imaging 2011; 4: 558-565.
18. Bottomley PA,. The trouble with spectroscopy papers. Radiology 1991; 181: 344-350.
19. 1H-MRS in the in vivo mouse heart: a comparison between PRESS and STEAM. In Proceedings of the 21st Annual Meeting of ISMRM, Salt Lake City, Utah, USA, 2013. p. 2011.
20. Schneider JE, Wiesmann F, Lygate CA, Neubauer S,. How to perform an accurate assessment of cardiac function in mice using high-resolution magnetic resonance imaging. J Cardiovasc Magn Reson 2006; 8: 693-701.
21. Bottomley PA,. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987; 508: 333-348.
22. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985; 30: 341-344.
23. Vanhamme L, van den Boogaart A, van Huffel S,. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129: 35-43.
24. Ugurbil K, Petein M, Maidan R, Michurski S, Cohn JN, From AH,. High resolution proton NMR studies of perfused rat hearts. FEBS Lett 1984; 167: 73-78.
25. 1H NMR spectroscopy. Magn Reson Med 2001; 46: 249-255.
26. 1H-MRS of the brain at 3 T: the effects of physiological motion. Magn Reson Med 2004; 51: 184-187.
27. 2 relaxation in rat brain in vivo. Magn Reson Med 2006; 56: 386-394.
28. 1 relaxation times of the neurochemical profile in rat brain at 9.4 Tesla and 14.1 Tesla. Magn Reson Med 2009; 62: 862-867.
29. 1 mapping of the mouse heart using variable flip angle steady-state MR imaging. NMR Biomed 2011; 24: 154-162.
30. Phillips D, ten Hove M, Schneider JE, et al., Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity. J Mol Cell Cardiol 2010; 48: 582-590.
31. Bakermans AJ, van Weeghel M, Denis S, Nicolay K, Prompers JJ, Houten SM,. Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice. J Inherit Metab Dis 2013; 36: 973-981.
32. 2 preparation. Magn Reson Med 2014; 72: 409-417.